Fifteen of 20 HLA-matched living donor recipients achieved the primary end point of being immunosuppression-free for more than two years.

Topline data were announced from a phase 3 trial that evaluated baxdrostat in patients with uncontrolled or treatment resistant hypertension.

Longer treatment duration, using semaglutide, higher percentage body fat, and nondiabetic status may be associated with better weight reduction.

Chemotherapy can increase mutation burden and change the cell population structure of normal blood, researchers found.

Standard IPC measures enabled safe provision of dialysis to patients with C. auris colonization or infection, without transmission.

Clinicians managing kidney transplant candidates with pulmonary hypertension need to be aware of possible excess risks.

Although progress has been made in improving kidney transplant access for women in the US, there is still much room for improvement.

(HealthDay News) — Consistently and increasingly accumulated physical activity (PA) is associated with a reduced risk for all-cause and cardiovascular disease (CVD) mortality, according to a review ...

The U.S. Centers for Disease Control and Prevention (CDC) estimates that 25 states are seeing growth in COVID cases as a summer wave appears to be starting, CBS News reported.

The approval was supported by data from the randomized, double-blind, placebo-controlled, event-driven phase 3 FINEARTS-HF study.

(HealthDay News) — Almost 15 percent of U.S. adults aged 50 to 80 years are taking aspirin for primary cardiovascular disease prevention, according to a brief report published in the July 1 issue of ...

The FDA has granted RMAT designation to detalimogene voraplasmid for the treatment of high-risk, BCG-unresponsive, NMIBC with CIS.